Fusion event
HBV-LOC101929322 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TTTTATCCAAAGGTTACCAAATATTTACCATTGGATAAGGGTATTAAACCTTATTATCCAGAACATCTAGTTAATCATTACTTCCAAACTAGACACTATT| |TACACACTCTATGGAAGGCGGGTATATTATATAAGAGAGAAACAACACATAGCGCCTCATTTTGTGGGTCACCATATTCTTGGGAACAAGATCTACAGCA
End
64960709/65495796 (Hg38)
Nearest miRNA
hsa-mir-1183/Upstream/816620; hsa-mir-10399/Downstream/1618526;
Upstream sequence
TTCCTCAACCTGTTGTGCTGTAAGCCTATTTTATTGATAAGAAAGAGCCAGACAAAATTGGCTGAAAATTAAAAATCTAGGTGACATATTTTAGAGGACT
Downstream sequence
CACTCCTGCTTTAAGAATACCCAAACAAATACATTCATTTATTTTTTTAGACTCTCAGAACACAGTTGATAGTTGAACTTGTAATCTATGATAATCAGCT
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.